In a report released today, Geoff Meacham from Citi maintained a Buy rating on Eli Lilly & Co (LLY – Research Report). The company’s shares ...

Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 4.9%. Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 3 years, compared ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...

Hao Hong is the esteemed chairman of Asymchem Laboratories, a Shenzhen-listed company renowned for its pharmaceutical outsourcing services.

Dragons’ Den investor Tej Lalvani, is reviving plans to sell the business, according to people familiar with the matter.